Inhibition of autoimmune diabetes by mycophenolate mofetil is associated with down-regulation of TH1 cytokine-induced apoptosis in the target tissue.
Stosic-Grujicic
S
S
Institute for Biological Research Sinisa Stankovic, School of Medicine, Belgrade University, Belgrade, Yugoslavia.
Maksimovic-Ivanic
D
D
Miljkovic
D
D
Trajkovic
V
V
Lukic
M
M
Mostarica Stojkovic
M
M
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D016207:Cytokines / Q000276:immunology*; D003921:Diabetes Mellitus, Experimental / Q000276:immunology* / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000517:prevention & control*; D004195:Disease Models, Animal; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D018417:Th1 Cells / Q000276:immunology*
D016207:Cytokines; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid